Literature DB >> 10421634

The von Hippel-Lindau tumor suppressor protein is a component of an E3 ubiquitin-protein ligase activity.

J Lisztwan1, G Imbert, C Wirbelauer, M Gstaiger, W Krek.   

Abstract

pVHL, the product of the VHL tumor suppressor gene, plays an important role in the regulation of cell growth and differentiation of human kidney cells, and inactivation of the VHL gene is the most frequent genetic event in human kidney cancer. The biochemical function of pVHL is unknown. Here we report that pVHL exists in vivo in a complex that displays ubiquitination-promoting activity in conjunction with the universally required components E1, E2, and ubiquitin. pVHL-associated ubiquitination activity requires, at a minimum, pVHL to bind elongin C and Cul-2, relatives of core components of SCF (Skp1-Cdc53/Cul-1-F-box protein) E3 ligase complexes. Notably, certain tumor-derived mutants of pVHL demonstrate loss of associated ubiquitination promoting activity. These results identify pVHL as a component of a potential SCF-like E3 ubiquitin-protein ligase complex and suggest a direct link between pVHL tumor suppressor and the process of ubiquitination.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10421634      PMCID: PMC316884          DOI: 10.1101/gad.13.14.1822

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  45 in total

1.  Reconstitution of G1 cyclin ubiquitination with complexes containing SCFGrr1 and Rbx1.

Authors:  D Skowyra; D M Koepp; T Kamura; M N Conrad; R C Conaway; J W Conaway; S J Elledge; J W Harper
Journal:  Science       Date:  1999-04-23       Impact factor: 47.728

Review 2.  How the cyclin became a cyclin: regulated proteolysis in the cell cycle.

Authors:  D M Koepp; J W Harper; S J Elledge
Journal:  Cell       Date:  1999-05-14       Impact factor: 41.582

3.  Protective function of von Hippel-Lindau protein against impaired protein processing in renal carcinoma cells.

Authors:  M Gorospe; J M Egan; B Zbar; M Lerman; L Geil; I Kuzmin; N J Holbrook
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

4.  The inducible elongin A elongation activation domain: structure, function and interaction with the elongin BC complex.

Authors:  T Aso; D Haque; R J Barstead; R C Conaway; J W Conaway
Journal:  EMBO J       Date:  1996-10-15       Impact factor: 11.598

5.  SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box.

Authors:  C Bai; P Sen; K Hofmann; L Ma; M Goebl; J W Harper; S J Elledge
Journal:  Cell       Date:  1996-07-26       Impact factor: 41.582

6.  Hypoxia-inducible protein binding to vascular endothelial growth factor mRNA and its modulation by the von Hippel-Lindau protein.

Authors:  A P Levy; N S Levy; M A Goldberg
Journal:  J Biol Chem       Date:  1996-10-11       Impact factor: 5.157

7.  Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein.

Authors:  O Iliopoulos; A P Levy; C Jiang; W G Kaelin; M A Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

8.  Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function.

Authors:  C E Stebbins; W G Kaelin; N P Pavletich
Journal:  Science       Date:  1999-04-16       Impact factor: 47.728

9.  Elongin (SIII): a multisubunit regulator of elongation by RNA polymerase II.

Authors:  T Aso; W S Lane; J W Conaway; R C Conaway
Journal:  Science       Date:  1995-09-08       Impact factor: 47.728

10.  Human CUL1 forms an evolutionarily conserved ubiquitin ligase complex (SCF) with SKP1 and an F-box protein.

Authors:  S A Lyapina; C C Correll; E T Kipreos; R J Deshaies
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

View more
  118 in total

1.  VHL: a very hip ligase.

Authors:  M Tyers; R Rottapel
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

2.  Covalent modifier NEDD8 is essential for SCF ubiquitin-ligase in fission yeast.

Authors:  F Osaka; M Saeki; S Katayama; N Aida; A Toh-E; K Kominami; T Toda; T Suzuki; T Chiba; K Tanaka; S Kato
Journal:  EMBO J       Date:  2000-07-03       Impact factor: 11.598

3.  Degradation of p53 by adenovirus E4orf6 and E1B55K proteins occurs via a novel mechanism involving a Cullin-containing complex.

Authors:  E Querido; P Blanchette; Q Yan; T Kamura; M Morrison; D Boivin; W G Kaelin; R C Conaway; J W Conaway; P E Branton
Journal:  Genes Dev       Date:  2001-12-01       Impact factor: 11.361

Review 4.  HIF hydroxylation and the mammalian oxygen-sensing pathway.

Authors:  Michal Safran; William G Kaelin
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

Review 5.  Getting into position: the catalytic mechanisms of protein ubiquitylation.

Authors:  Lori A Passmore; David Barford
Journal:  Biochem J       Date:  2004-05-01       Impact factor: 3.857

Review 6.  HECT and RING finger families of E3 ubiquitin ligases at a glance.

Authors:  Meredith B Metzger; Ventzislava A Hristova; Allan M Weissman
Journal:  J Cell Sci       Date:  2012-02-01       Impact factor: 5.285

Review 7.  Inhibition of NEDD8-conjugation pathway by novel molecules: potential approaches to anticancer therapy.

Authors:  Tomoaki Tanaka; Tatsuya Nakatani; Tetsu Kamitani
Journal:  Mol Oncol       Date:  2012-01-21       Impact factor: 6.603

8.  von Hippel-Lindau mutation in mice recapitulates Chuvash polycythemia via hypoxia-inducible factor-2alpha signaling and splenic erythropoiesis.

Authors:  Michele M Hickey; Jennifer C Lam; Natalie A Bezman; W Kimryn Rathmell; M Celeste Simon
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

9.  Erythropoietin inhibits HIF-1α expression via upregulation of PHD-2 transcription and translation in an in vitro model of hypoxia-ischemia.

Authors:  Rhonda Souvenir; Jerry J Flores; Robert P Ostrowski; Anatol Manaenko; Kamil Duris; Jiping Tang
Journal:  Transl Stroke Res       Date:  2013-11-27       Impact factor: 6.829

Review 10.  Metabolic Regulation of Apoptosis in Cancer.

Authors:  K Matsuura; K Canfield; W Feng; M Kurokawa
Journal:  Int Rev Cell Mol Biol       Date:  2016-07-30       Impact factor: 6.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.